Harrow Shares Rise Following Higher-Than-Expected 4Q Preliminary Results

Dow Jones03-17

By Connor Hart

Shares of Harrow rose after the company's preliminary fourth-quarter results came in ahead of Wall Street's expectations.

The stock gained 19%, to $27.73, in after-hours trading Monday. Shares have more than doubled in the past 52 weeks, despite having lost nearly one-third of their value since the beginning of the year.

The eyecare pharmaceutical company said after the bell it expects to report a profit of $5 million to $7 million on revenue of $65 million to $67 million in the fourth quarter. Analysts surveyed by FactSet expected a fourth-quarter loss of $300,000 on sales of $58.4 million.

Chief Executive Mark Baum additionally provided an initial 2025 outlook that calls for revenue of over $280 million. Analysts modeled sales of $281.2 million for the year.

Harrow had planned to release its audited financial statements Monday after the bell, but the company's new auditor required additional time to prepare its financial presentation.

"We remain fully committed to comprehensive, accurate and transparent financial reporting," Baum said.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

March 17, 2025 18:59 ET (22:59 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2520668014?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-18 06:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2520668014","market":"fut","top_or_hot":-1,"title":"Harrow Shares Rise Following Higher-Than-Expected 4Q Preliminary Results","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Connor Hart \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Harrow rose after the company's preliminary fourth-quarter results came in ahead of Wall Street's expectations. \n</p>\n<p>\n  The stock gained 19%, to $27.73, in after-hours trading Monday. Shares have more than doubled in the past 52 weeks, despite having lost nearly one-third of their value since the beginning of the year. \n</p>\n<p>\n  The eyecare pharmaceutical company said after the bell it expects to report a profit of $5 million to $7 million on revenue of $65 million to $67 million in the fourth quarter. Analysts surveyed by FactSet expected a fourth-quarter loss of $300,000 on sales of $58.4 million. \n</p>\n<p>\n  Chief Executive Mark Baum additionally provided an initial 2025 outlook that calls for revenue of over $280 million. Analysts modeled sales of $281.2 million for the year. \n</p>\n<p>\n  Harrow had planned to release its audited financial statements Monday after the bell, but the company's new auditor required additional time to prepare its financial presentation. \n</p>\n<p>\n  \"We remain fully committed to comprehensive, accurate and transparent financial reporting,\" Baum said. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 17, 2025 18:59 ET (22:59 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Harrow Shares Rise Following Higher-Than-Expected 4Q Preliminary Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHarrow Shares Rise Following Higher-Than-Expected 4Q Preliminary Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-18 06:59</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Connor Hart \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Harrow rose after the company's preliminary fourth-quarter results came in ahead of Wall Street's expectations. \n</p>\n<p>\n  The stock gained 19%, to $27.73, in after-hours trading Monday. Shares have more than doubled in the past 52 weeks, despite having lost nearly one-third of their value since the beginning of the year. \n</p>\n<p>\n  The eyecare pharmaceutical company said after the bell it expects to report a profit of $5 million to $7 million on revenue of $65 million to $67 million in the fourth quarter. Analysts surveyed by FactSet expected a fourth-quarter loss of $300,000 on sales of $58.4 million. \n</p>\n<p>\n  Chief Executive Mark Baum additionally provided an initial 2025 outlook that calls for revenue of over $280 million. Analysts modeled sales of $281.2 million for the year. \n</p>\n<p>\n  Harrow had planned to release its audited financial statements Monday after the bell, but the company's new auditor required additional time to prepare its financial presentation. \n</p>\n<p>\n  \"We remain fully committed to comprehensive, accurate and transparent financial reporting,\" Baum said. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 17, 2025 18:59 ET (22:59 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2520668014","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2520668014","pubTimestamp":1742252340,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Harrow rose after the company's preliminary fourth-quarter results came in ahead of Wall Street's expectations.The stock gained 19%, to $27.73, in after-hours trading Monday. Shares have more than doubled in the past 52 weeks, despite having lost nearly one-third of their value since the beginning of the year.The eyecare pharmaceutical company said after the bell it expects to report a profit of $5 million to $7 million on revenue of $65 million to $67 million in the fourth quarter. Analysts surveyed by FactSet expected a fourth-quarter loss of $300,000 on sales of $58.4 million.Chief Executive Mark Baum additionally provided an initial 2025 outlook that calls for revenue of over $280 million. Analysts modeled sales of $281.2 million for the year.Harrow had planned to release its audited financial statements Monday after the bell, but the company's new auditor required additional time to prepare its financial presentation.\"We remain fully committed to comprehensive, accurate ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"哈罗股价因第四季度初步业绩高于预期而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HROW":0.9},"content_text":"By Connor Hart \n\n\n \n\n\n  Shares of Harrow rose after the company's preliminary fourth-quarter results came in ahead of Wall Street's expectations. \n\n\n  The stock gained 19%, to $27.73, in after-hours trading Monday. Shares have more than doubled in the past 52 weeks, despite having lost nearly one-third of their value since the beginning of the year. \n\n\n  The eyecare pharmaceutical company said after the bell it expects to report a profit of $5 million to $7 million on revenue of $65 million to $67 million in the fourth quarter. Analysts surveyed by FactSet expected a fourth-quarter loss of $300,000 on sales of $58.4 million. \n\n\n  Chief Executive Mark Baum additionally provided an initial 2025 outlook that calls for revenue of over $280 million. Analysts modeled sales of $281.2 million for the year. \n\n\n  Harrow had planned to release its audited financial statements Monday after the bell, but the company's new auditor required additional time to prepare its financial presentation. \n\n\n  \"We remain fully committed to comprehensive, accurate and transparent financial reporting,\" Baum said. \n\n\n \n\n\n  Write to Connor Hart at connor.hart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 17, 2025 18:59 ET (22:59 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2520668014"}